Monitoring and Outcomes of Central LineAssociated Bloodstream Infections in a Tertiary Care Intensive Care Unit

被引:0
作者
Kharduit, Peter B. [1 ]
Dutta, Kaustuv [2 ]
Lyngdoh, Clarissa J. [1 ]
Bhattacharyya, Prithwis [3 ]
Lyngdoh, Valarie [4 ]
Khyriem, Annie B. [1 ]
Devi, Suriya K. [1 ]
机构
[1] North Eastern Indira Gandhi Reg Inst Hlth & Med Sc, Microbiol, Shillong, India
[2] North Eastern Indira Gandhi Reg Inst Hlth & Med Sc, Anesthesiol, Shillong, India
[3] North Eastern Indira Gandhi Reg Inst Hlth & Med Sc, Anesthesiol & Crit Care, Shillong, India
[4] North Eastern Indira Gandhi Reg Inst Hlth & Med Sc, Clin Microbiol, Shillong, India
关键词
multidrug-resistant organisms; device utilization ratio; infection control; surveillance; central line- associated bloodstream infection; RISK; MORTALITY;
D O I
10.7759/cureus.63428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Central line-associated bloodstream infections (CLABSIs) are significant healthcare-associated infections that increase morbidity, mortality, and healthcare costs. This study aims to analyze the frequency, microbiology, risk factors, and outcomes of CLABSI in an adult intensive care unit. Methods We conducted a hospital-based, prospective surveillance study in the critical care unit of a tertiary care hospital. We included patients with a central line (CL) from admission until discharge or line removal. Data collection focused on patient demographics, comorbidities, CL insertion site, and CLABSI rates. The incidence of CLABSI was calculated per 1,000 CL-days, and statistical analysis was performed using the Chisquare test. Results Of the 169 patients enrolled, 123 episodes of bloodstream infections were recorded, 56 (45.5%) of which were CLABSIs. The organisms most frequently isolated were Klebsiella pneumoniae (n = 14; 24.6%), Enterobacter cloacae complex (n = 11; 19.3%), Klebsiella species (n = 7; 12.28%), and Acinetobacter baumannii (n = 7; 12.28%). The overall CLABSI rate was 24.70 per 1,000 CL-days. No significant association was found between CLABSI and patient age, gender, or the site of CL insertion. However, a significant relationship was observed between CLABSI and the presence of comorbid conditions (p = 0.001). The study also noted a high rate of antibiotic resistance among the isolated pathogens. Conclusions Our results emphasize the need for stringent infection control measures and suggest that comorbid conditions significantly increase the risk of CLABSI. Addressing antibiotic resistance and implementing effective prevention strategies are essential for reducing the burden of CLABSIs.
引用
收藏
页数:11
相关论文
共 30 条
[1]   Central Line-associated Bloodstream Infections in Cancer Patients: An Experience from a Tertiary Care Cancer Centre [J].
Agrawal, Sonu Kumari ;
Gautam, Hitender ;
Choudhary, Abdul Hakim ;
Das, Bimal Kumar ;
Kumar, Lalit ;
Kapil, Arti .
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 37 (03) :376-380
[2]   Length of Stay in Patients With Central Line-Associated Bloodstream Infection at a Tertiary Hospital in the Kingdom of Saudi Arabia [J].
Alotaibi, Naif H. ;
Barri, Abdulrahman ;
Elahi, Muhammad A. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
[3]   Clinical Impacts and Risk Factors for Central Line-Associated Bloodstream Infection: A Systematic Review [J].
Alshahrani, Khadejah M. ;
Alhuwaishel, Afnan Z. ;
Alangari, Norah M. ;
Asiri, Malak A. ;
Al -Shahrani, Norah A. ;
Alasmari, Ahmed A. ;
Alzahrani, Osama J. ;
Ayedh, Abdulaziz Y. ;
Qitmah, Meshari M. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
[4]   Microbiological trends and mortality risk factors of central line-associated bloodstream infections in an academic medical center 2015-2020 [J].
Alwazzeh, Marwan Jabr ;
Alnimr, Amani ;
Al Nassri, Samia A. ;
Alwarthan, Sara M. ;
Alhajri, Mashael ;
AlShehail, Bashayer M. ;
Almubarak, Mahdi ;
Alghamdi, Nada S. ;
Wali, Haytham A. .
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2023, 12 (01)
[5]   Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line-associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic [J].
Ben-Aderet, Michael A. ;
Madhusudhan, Meghan S. ;
Haroun, Pishoy ;
Almario, Matthew J. P. ;
Raypon, Ryan ;
Fawcett, Sharon ;
Johnson, Julie ;
Girard, Anita ;
Griner, Todd ;
Sheffield, Lorraine ;
Grein, Jonathan D. .
INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (07) :1108-1115
[6]   Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update [J].
Buetti, Niccolo ;
Marschall, Jonas ;
Drees, Marci ;
Fakih, Mohamad G. ;
Hadaway, Lynn ;
Maragakis, Lisa L. ;
Monsees, Elizabeth ;
Novosad, Shannon ;
O'Grady, Naomi P. ;
Rupp, Mark E. ;
Wolf, Joshua ;
Yokoe, Deborah ;
Mermel, Leonard A. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (05) :553-569
[7]   Risk factors of catheter- associated bloodstream infection: Systematic review and meta-analysis [J].
Cabrero, Elisabeth Lafuente ;
Robledo, Roser Terradas ;
Cunado, Anna Civit ;
Sardelli, Diana Garcia ;
Lopez, Carlota Hidalgo ;
Formatger, Dolors Giro ;
Perez, Laia Lacueva ;
Lopez, Cristina Esquinas ;
Moreno, Avelina Tortosa .
PLOS ONE, 2023, 18 (03)
[8]   Indwelling time of peripherally inserted central catheters and incidence of bloodstream infections in haematology patients: a cohort study [J].
Caris, M. G. ;
de Jonge, N. A. ;
Punt, H. J. ;
Salet, D. M. ;
de Jong, V. M. T. ;
Lissenberg-Witte, B., I ;
Zweegman, S. ;
Vandenbroucke-Grauls, C. M. J. E. ;
van Agtmael, M. A. ;
Janssen, J. J. W. M. .
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
[9]  
cdc, 2022, Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection)
[10]  
Haddadin Y., 2024, STATPEARLS